TEVA 7238 (Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg)
Pill imprint TEVA 7238 has been identified as Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg.
Hydrochlorothiazide/irbesartan is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/irbesartan 12.5 mg / 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for TEVA 7238
- 12.5 mg / 150 mg
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
ferric oxide yellow
More about hydrochlorothiazide/irbesartan
- Hydrochlorothiazide and irbesartan
- Irbesartan and hydrochlorothiazide (Advanced Reading)
- Other brands: Avalide
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.